Fundraising Fox

PJ Krohl

Investor

Founder / EIR at 82VS

Cambridge, Massachusetts, United States

About

PJ Krohl is Co-Founder and Chief Scientific Officer of Overture Therapeutics, focused on antibody medicines for obesity and metabolic disease. He previously co-founded PerformAb, a company addressing antibody discovery for challenging targets including GPCRs and ion channels, which was acquired by Alloy Therapeutics where the platform continues to support partner programs. Krohl holds a Ph.D. in Chemical and Biomolecular Engineering from Johns Hopkins and has conducted research in antibody discovery against complex membrane targets.

Experience

  1. Overture TherapeuticsCo-Founder & CSOcurrent2024 — presentCambridge, Massachusetts, United States
  2. Alloy Therapeutics, Inc.Head of In Vitro Discovery and Optimization2024 — 2025Waltham, Massachusetts, United States
  3. 82VSEntrepreneur-in-Residence2023 — 2025Waltham, Massachusetts, United States
  4. PerformAbCo-Founder and CEO2021 — 2025Baltimore, Maryland, United States
  5. Integral MolecularProject Manager2022 — 2023Philadelphia, Pennsylvania, United States
  6. The Johns Hopkins UniversityGraduate Student2017 — 2022Baltimore, Maryland, United States
  7. University at BuffaloResearch Assistant2015 — 2017Amherst, New York, United States
  8. Colorado School of MinesResearch Assistant2016Golden, Colorado, United States

Education

  1. The Johns Hopkins UniversityDoctor of Philosophy - PhD, Chemical and Biomolecular Engineering2017 — 2022
  2. University at BuffaloBachelor of Science - BS, Chemical and Biological Engineering2014 — 2017

Colleagues at 82VS

Andrei Ramirez-Valdez
Venture Associate at 82VS
Andrew Peterson
Founder / EIR at 82VS
Arthur Suckow
Investor at 82VS
Caitlin Tolman
Chief Operating Officer at 82VS
Carlos Loya
Venture Partner & Founder at 82VS
Colby Jordan
Vice President, Capital Formation at 82VS
Dongxing Zha
Founder / EIR at 82VS
Errik Anderson
Board Director at Basecamp Fund

Frequently asked questions

Where does PJ Krohl work?
PJ Krohl is Founder / EIR at 82VS.

Same school

Also attended The Johns Hopkins University245

Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General CatalystScott RubinVenture Partner at Lux Capital

+ 239 more

Also attended University at Buffalo56

Ariel LebowitsCFO at FJ LabsRyan ScottInvestor at Khosla VenturesDavid OppenheimerPartner, CFO at Verissimo VenturesKevin DunlapCo-Founder and Managing Partner at Calibrate VenturesRichard LungenGeneral Partner at HC9 VenturesBob ClericiFund Operations at HC9 Ventures

+ 50 more

Shared employers

Also worked at Overture Therapeutics1

Russell BeckermanFounder / EIR at 82VS

Also worked at Alloy Therapeutics, Inc.20

Jesse RobbinsFounder and Investor in AI Developer ToolsChaya PatelPrincipal at Mission BiocapitalErrik AndersonBoard Director at Basecamp FundAlasdair ThongFounding Partner at Selvedge VentureEsra BerkolChief of Staff at Selvedge VentureMike SchmidtGeneral Partner, President and Head of 82VS Boston at 82VS

+ 14 more

Also worked at Integral Molecular1

Margalit HaberAssociate at OUP (Osage University Partners)

Also worked at The Johns Hopkins University52

Demi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesLinda CuretonBoard Member at Maryland TEDCODavid NarrowVenture Advisor at Cultivation CapitalCharlie BuffaVice President, Sales at Mainsail PartnersOluwakayode (Kay) JasanyaInvestor at SUPPLY CHANGE CAPITAL

+ 46 more